BBNX Investors: Beta Bionics, Inc. Shares Declined By $11.85 On January 9, 2026 -- Contact Kirby McInerney LLP to Discuss Your Rights
Kirby McInerney LLP issued a solicitation seeking a lead plaintiff for a securities fraud class action against Beta Bionics, with a November 3, 2026 deadline. The suit covers purchasers from July 30, 2025 through February 24, 2026 and alleges Beta Bionics concealed iLet insulin pump malfunctions, an FDA Form 483, thousands of back-filed complaints, and inadequate corrective action.
Key figures
- Class period
- July 30, 2025 through February 24, 2026
- Jan 9 price drop
- -$11.85 (-37%) to $20.14
- Feb 25 price drop
- -$0.50 (-3.7%) to $12.89
- Jan 30 price drop
- -$0.96 (-6.5%) to $13.83
- Lead plaintiff deadline
- November 3, 2026
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.